Navigation Links
Scientific Research & Development in the US Industry Market Research Report from IBISWorld has Been Updated
Date:12/11/2012

Los Angeles, CA (PRWEB) December 11, 2012

“Increased funding from the government, corporations and academia has benefited the Scientific Research and Development industry,” according to IBISWorld industry analyst Kevin Boyland. As a result, IBISWorld expects industry revenue to increase at an annualized rate of 4.1% over the five years to 2012 to total $118.4 billion. However, revenue growth is expected to slow to 1.4% in 2012 following a dip in government spending in 2011 and an ongoing budget dispute on Capitol Hill. Federal funding is expected to contribute about 61.3% of industry revenue in 2012; other government funding is expected to contribute 4.0%.

While still overwhelmingly funded by public sources, a shift toward private funding is slowly changing the focus of industry research. Historically, government money has been devoted to basic research, or research without a specific goal. However, private and corporate money is often devoted to experimental and developmental research that builds upon an existing idea often already developed by basic research. This type of research and development (R&D) is far more financially viable, and companies have been more inclined to invest in it to gain a competitive advantage over the past five years. Nonetheless, there are no major players in the Scientific Research and Development industry, and the multitude of research topics undertaken by the industry precludes any one firm from gaining a dominant position. “Although players in the industry have made some acquisitions over the five years to 2012, concentration has only slightly increased,” says Boyland.

The industry will continue to benefit from growing environmental concerns throughout the public and private sector. A significant slice of recent stimulus spending was targeted at renewable energy jobs, highlighting this growing concern. Over the five years to 2017, increasing investment into scientific R&D is forecast to expand industry revenue at a steady rate. Continued interest in R&D from the private sector is also expected to increase investment in the industry moving forward. Nevertheless, the industry will remain largely dependent on funding from the federal government. This dependence is highlighted by the impending sequestration of federal funds (known as the fiscal cliff) that will come into effect in January 2013 if Congress and the President cannot agree on a deficit reduction plan. If the sequestration takes effect, the industry stands to lose tens of thousands of jobs and a dramatic amount of funding. For more information, visit IBISWorld’s Scientific Research & Development in the US industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld industry Report Key Topics

This industry includes companies and organizations that are involved in physical, engineering or life sciences research and development (R&D). The industry only includes firms whose primary purpose is R&D and excludes players such as pharmaceutical or manufacturing companies that may undertake R&D to support their primary operations. Government entities are also excluded from this industry, although these entities may contract and fund the research this industry undertakes.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10225031.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
2. VisionGate Reports Advances In Its Cell-CT(TM) Automated 3D Cell Analysis Platform At ASC 2012 Scientific Meeting
3. No on Prop. 37: French Rat Study Author Made Reporters Sign Confidentiality Agreements Prohibiting them from Consulting Independent Scientific Experts
4. TREVENTIS Corporation Scientific Founder, Donald Weaver, MD, Named Sobey Chair in Alzheimers Disease Research, His Third Endowed Chair
5. New England Biolabs Demonstrates Support for Interactive Scientific Literature by Collaborating with AQnowledge
6. UAS Laboratories Presents about Probiotic Selection Criteria, at Scientific Conference
7. The Energy Scientific World Acclaims the Global Energy Prize 2012 Laureates
8. Traumatic Brain Injury the Focus of American Headache Society Scientific Conference
9. Althea Technologies Appoints Dr. Dennis Fenton As Chairman Of Its Scientific Advisory Board
10. Sapphire Energy Names New Scientific Advisory Board
11. Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , ... December 01, 2016 , ... ... long-term client Nanowear on their recent FDA Class II 510(k) clearance for their ... significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. ...
(Date:12/2/2016)... a world leader in rapid infectious disease tests, introduced the Company,s newest product, the ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited by the ... INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... Biotest Pharmaceuticals Corporation (BPC), a leading manufacturer ... addition of its newest plasma collection center located at ... The 15,200 square foot state-of-the-art facility officially opened its ... the total number of BPC,s plasma collection centers to ... Chief Executive Officer said "We are pleased to become ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
Breaking Biology Technology:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
(Date:11/22/2016)... According to the new market research report "Biometric ... Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, ... is expected to grow from USD 10.74 Billion in 2015 to reach ... and 2022. Continue Reading ... ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
Breaking Biology News(10 mins):